Greenwich Lifesciences Stock Analysis

GLSI Stock  USD 11.25  0.14  1.26%   
Greenwich Lifesciences is undervalued with Real Value of 17.68 and Hype Value of 11.0. The main objective of Greenwich Lifesciences stock analysis is to determine its intrinsic value, which is an estimate of what Greenwich Lifesciences is worth, separate from its market price. There are two main types of Greenwich Lifesciences' stock analysis: fundamental analysis and technical analysis.
The Greenwich Lifesciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Greenwich Lifesciences' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Greenwich Lifesciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more detail on how to invest in Greenwich Stock please use our How to Invest in Greenwich Lifesciences guide.

Greenwich Stock Analysis Notes

About 53.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.81. Greenwich Lifesciences had not issued any dividends in recent years. Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2neu-expressing cancers. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Greenwich Lifesciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. To learn more about Greenwich Lifesciences call Snehal Patel at 832 819 3232 or check out https://greenwichlifesciences.com.

Greenwich Lifesciences Investment Alerts

Greenwich Lifesciences generated a negative expected return over the last 90 days
Greenwich Lifesciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (8.89 M) with profit before overhead, payroll, taxes, and interest of 0.
Greenwich Lifesciences currently holds about 15.64 M in cash with (6.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22.
Greenwich Lifesciences has a frail financial position based on the latest SEC disclosures
Roughly 53.0% of the company shares are held by company insiders

Greenwich Lifesciences Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Greenwich Lifesciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
29th of March 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Greenwich Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 146.04 M.

Technical Drivers

As of the 25th of March, Greenwich Lifesciences retains the Risk Adjusted Performance of (0.02), standard deviation of 2.96, and Market Risk Adjusted Performance of 0.2834. Greenwich Lifesciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Greenwich Lifesciences Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Greenwich Lifesciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Greenwich Lifesciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Greenwich Lifesciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Greenwich Lifesciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Greenwich Lifesciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Greenwich Lifesciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Jaye Thompson over a week ago
Acquisition by Jaye Thompson of 149818 shares of Greenwich Lifesciences at 12.16 subject to Rule 16b-3
 
Snehal Patel over two weeks ago
Acquisition by Snehal Patel of 12000 shares of Greenwich Lifesciences at 8.33 subject to Rule 16b-3
 
Snehal Patel over three weeks ago
Acquisition by Snehal Patel of 2000 shares of Greenwich Lifesciences at 9.72 subject to Rule 16b-3
 
Snehal Patel over two months ago
Acquisition by Snehal Patel of 2500 shares of Greenwich Lifesciences at 12.51 subject to Rule 16b-3
 
Snehal Patel over two months ago
Acquisition by Snehal Patel of 3200 shares of Greenwich Lifesciences at 11.12 subject to Rule 16b-3
 
Mcwilliams David over two months ago
Acquisition by Mcwilliams David of 61984 shares of Greenwich Lifesciences at 12.16 subject to Rule 16b-3
 
Jaye Thompson over three months ago
Acquisition by Jaye Thompson of 1000 shares of Greenwich Lifesciences at 12.91 subject to Rule 16b-3
 
Snehal Patel over three months ago
Acquisition by Snehal Patel of 2000 shares of Greenwich Lifesciences at 9.72 subject to Rule 16b-3
 
Snehal Patel over three months ago
Acquisition by Snehal Patel of 12000 shares of Greenwich Lifesciences at 7.91 subject to Rule 16b-3
 
Snehal Patel over three months ago
Acquisition by Snehal Patel of 1500 shares of Greenwich Lifesciences at 14.63 subject to Rule 16b-3
 
Snehal Patel over six months ago
Acquisition by Snehal Patel of 2000 shares of Greenwich Lifesciences at 13.81 subject to Rule 16b-3
 
Snehal Patel over six months ago
Acquisition by Snehal Patel of 5500 shares of Greenwich Lifesciences at 13.18 subject to Rule 16b-3

Greenwich Lifesciences Outstanding Bonds

Greenwich Lifesciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Greenwich Lifesciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Greenwich bonds can be classified according to their maturity, which is the date when Greenwich Lifesciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Greenwich Lifesciences Predictive Daily Indicators

Greenwich Lifesciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Greenwich Lifesciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Greenwich Lifesciences Forecast Models

Greenwich Lifesciences' time-series forecasting models are one of many Greenwich Lifesciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Greenwich Lifesciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Greenwich Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Greenwich Lifesciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Greenwich shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Greenwich Lifesciences. By using and applying Greenwich Stock analysis, traders can create a robust methodology for identifying Greenwich entry and exit points for their positions.
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2neu-expressing cancers. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Greenwich Lifesciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Greenwich Lifesciences to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences' price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios